Results 121 to 130 of about 7,241 (205)

Treatment of High-Risk Idiopathic Membranous Nephropathy with Huaier Granules and RASi: A Case Series

International Medical Case Reports Journal
Tingyi Zhao, Hua Liang, Xiangdong Yang, Xiaoyan Xiao Department of Nephrology, Qilu Hospital of Shandong University, Jinan City, Shandong, People’s Republic of ChinaCorrespondence: Xiaoyan Xiao, Email xiaoyanxiao2007@163.comAbstract: Huaier Granules, an ...
Zhao T, Liang H, Yang X, Xiao X
doaj  

Is Rituximab Suitable for Patients with Idiopathic Membranous Nephropathy Who are Seronegative for Anti-PLA2R Antibody? [PDF]

Drug Des Devel Ther
Yang Y, Xie X, Yuan F, Zeng F, Wang Y, Zhang R, Yan W, Luo K, Ren D, Xu G.   +9 more
europepmc   +1 more source

INPP5D/SHIP1-mediated immunometabolic remodeling of renal monocytes in idiopathic membranous nephropathy. [PDF]

Front Immunol
Dai H, Liu B, Rui H, Yang L, Jiang H, Zhao Q, Liu W.   +6 more
europepmc   +1 more source

FSTIV score is essential for clinical management and predicts outcome of idiopathic membranous nephropathy. [PDF]

BMC Nephrol
Liu Y, Wang M, Yang L, Ma J, Zhang G, Bao L, Ma L, Xia W, Zheng Y.   +8 more
europepmc   +1 more source

Evolution of idiopathic membranous nephropathy to class v lupus nephritis: a case report and literature review. [PDF]

Front Med (Lausanne)
Shen B, Peng C, Xiao W.
europepmc   +1 more source

Baicalin ameliorates podocyte injury and renal function impairment in idiopathic membranous nephropathy by inhibiting the AGE/RAGE signaling. [PDF]

Ren Fail
Lou C, Zhou Y, Feng B, Fan X, Xu X, Hu P, Wang X.   +6 more
europepmc   +1 more source

Clinicopathological characteristics and outcomes in patients with diabetic nephropathy coexisting idiopathic membranous nephropathy: a retrospective observational study. [PDF]

Ren Fail
Li Z, Han Y, Yuan S, Xiao L, Zhu X, Sun L.   +5 more
europepmc   +1 more source

Evaluating rituximab against cyclophosphamide or cyclosporine in idiopathic membranous nephropathy: a meta-analysis. [PDF]

Eur J Med Res
Zhang Y, Chen H, Zhang H, Huang Y.
europepmc   +1 more source

Correction: Effectiveness and safety of rituximab monotherapy versus conventional regimens for adult idiopathic membranous nephropathy: real-world retrospective study. [PDF]

Front Immunol
Frontiers Production Office .
europepmc   +1 more source

Serum and urine anti-PLA2R antibody correlation with albuminuria in idiopathic membranous nephropathy. [PDF]

Front Immunol
Liu X, Fu Y, Sui M, Wang X, Li Z.
europepmc   +1 more source